-
1.HETEROARYLAMINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES 审中-公开
标题翻译: 用于治疗糖尿病的异丙基氨基吡唑衍生物公开(公告)号:US20090209451A1
公开(公告)日:2009-08-20
申请号:US12422804
申请日:2009-04-13
申请人: Joachim Rudolph , Phillip Wickens , Chih-Yuan Chuang , Libing Chen , Steven Magnuson , Alan Olague , Ning Qi
发明人: Joachim Rudolph , Phillip Wickens , Chih-Yuan Chuang , Libing Chen , Steven Magnuson , Alan Olague , Ning Qi
IPC分类号: A61K38/02 , C07D401/12 , A61K31/4439 , A61K31/506 , C07D403/12 , C07D413/14 , A61K31/5377 , A61P3/10
CPC分类号: C07D401/12 , C07D403/12 , C07D405/12 , C07D409/14
摘要: The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
摘要翻译: 本发明涉及杂芳基氨基吡唑化合物,药物组合物和治疗糖尿病和相关疾病的方法。
-
2.
公开(公告)号:US20080064734A1
公开(公告)日:2008-03-13
申请号:US11897620
申请日:2007-08-31
申请人: Joachim Rudolph , Louis-David Cantin , Steven Magnuson , William Bullock , Ann-Marie Bullion , Libing Chen , Chih-Yuan Chuang , Sidney Liang , Dyuti Majumdar , Herbert Ogutu , Alan Olague , Ning Qi , Philip Wickens
发明人: Joachim Rudolph , Louis-David Cantin , Steven Magnuson , William Bullock , Ann-Marie Bullion , Libing Chen , Chih-Yuan Chuang , Sidney Liang , Dyuti Majumdar , Herbert Ogutu , Alan Olague , Ning Qi , Philip Wickens
IPC分类号: A61K31/415 , A61P3/04 , C07D231/10
CPC分类号: C07D231/38 , C07D401/04 , C07D403/12 , C07D413/12 , C07D471/04
摘要: The present invention relates to anilinopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
摘要翻译: 本发明涉及苯胺基吡唑化合物,药物组合物和治疗糖尿病及相关疾病的方法。
-
3.Heteroarylaminopyrazole derivatives useful for the treatment of diabetes 失效
标题翻译: 可用于治疗糖尿病的杂芳基氨基吡唑衍生物公开(公告)号:US07517878B2
公开(公告)日:2009-04-14
申请号:US11064700
申请日:2005-02-24
申请人: Joachim Rudolph , Philip Wickens , Chih-Yuan Chuang , Libing Chen , Steven Magnuson , Alan Olague , Ning Qi
发明人: Joachim Rudolph , Philip Wickens , Chih-Yuan Chuang , Libing Chen , Steven Magnuson , Alan Olague , Ning Qi
IPC分类号: C07D403/12 , A61K31/4155
CPC分类号: C07D401/12 , C07D403/12 , C07D405/12 , C07D409/14
摘要: The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
摘要翻译: 本发明涉及杂芳基氨基吡唑化合物,药物组合物和治疗糖尿病和相关疾病的方法。
-
公开(公告)号:US07265144B2
公开(公告)日:2007-09-04
申请号:US10719485
申请日:2003-11-21
申请人: Joachim Rudolph , Louis-David Cantin , Steven Magnuson , William Bullock , Ann-Marie Bullion , Libing Chen , Chih-Yuan Chuang , Sidney Liang , Dyuti Majumdar , Herbert Ogutu , Alan Olague , Ning Qi , Philip L. Wickens
发明人: Joachim Rudolph , Louis-David Cantin , Steven Magnuson , William Bullock , Ann-Marie Bullion , Libing Chen , Chih-Yuan Chuang , Sidney Liang , Dyuti Majumdar , Herbert Ogutu , Alan Olague , Ning Qi , Philip L. Wickens
IPC分类号: A61K31/4152 , C07D231/44
CPC分类号: C07D231/38 , C07D401/04 , C07D403/12 , C07D413/12 , C07D471/04
摘要: The present invention relates to anilinopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
摘要翻译: 本发明涉及苯胺基吡唑化合物,药物组合物和治疗糖尿病及相关疾病的方法。
-
5.Heteroarylaminopyrazole derivatives useful for the treatment of diabetes 失效
标题翻译: 可用于治疗糖尿病的杂芳基氨基吡唑衍生物公开(公告)号:US20050192294A1
公开(公告)日:2005-09-01
申请号:US11064700
申请日:2005-02-24
申请人: Joachim Rudolph , Philip Wickens , Chih-Yuan Chuang , Libing Chen , Steven Magnuson , Alan Olague , Ning Qi
发明人: Joachim Rudolph , Philip Wickens , Chih-Yuan Chuang , Libing Chen , Steven Magnuson , Alan Olague , Ning Qi
IPC分类号: A61K31/4155 , A61K31/4439 , A61K31/506 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/14 , C07D43/02
CPC分类号: C07D401/12 , C07D403/12 , C07D405/12 , C07D409/14
摘要: The present invention relates to heteroarylaminopyrazole compounds, pharmaceutical compositions, and methods for treating diabetes and related disorders.
摘要翻译: 本发明涉及杂芳基氨基吡唑化合物,药物组合物和治疗糖尿病和相关疾病的方法。
-
6.
公开(公告)号:US08138336B2
公开(公告)日:2012-03-20
申请号:US12679787
申请日:2008-09-22
申请人: Steven Magnuson , Philip Wickens , Zhonghua Zhang , Ning Qi , Xin Ma
发明人: Steven Magnuson , Philip Wickens , Zhonghua Zhang , Ning Qi , Xin Ma
IPC分类号: C07D487/04 , C07D417/02 , C07D413/02 , A61K31/53 , A61P35/00
CPC分类号: C07D487/04
摘要: This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly Cancer.
-
7.PYRROLOTRIAZINE DERIVATIVES USEFUL FOR TREATING CANCER THROUGH INHIBITION OF AURORA KINASE 有权
标题翻译: 用于通过抑制激素激酶治疗癌症的吡咯烷酮衍生物公开(公告)号:US20100273800A1
公开(公告)日:2010-10-28
申请号:US12679787
申请日:2008-09-22
申请人: Steven Magnuson , Philip Wickens , Zhonghua Zhang , Ning Qi , Xin Ma
发明人: Steven Magnuson , Philip Wickens , Zhonghua Zhang , Ning Qi , Xin Ma
IPC分类号: A61K31/53 , C07D253/10 , C12N9/99 , A61P35/00 , A61J1/05
CPC分类号: C07D487/04
摘要: This invention relates to novel compounds and processes for their preparation, methods of treating diseases, particularly Cancer, comprising administering said compounds, and methods of making pharmaceutical compositions for the treatment or prevention of disorders, particularly Cancer.
摘要翻译: 本发明涉及新化合物及其制备方法,治疗疾病,特别是癌症的方法,包括给药所述化合物,以及制备用于治疗或预防病症,特别是癌症的药物组合物的方法。
-
8.2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists 审中-公开
标题翻译: 用作β-3肾上腺素受体激动剂的2,6-取代的苯并二氢吡喃衍生物公开(公告)号:US20050215594A1
公开(公告)日:2005-09-29
申请号:US11117759
申请日:2005-04-28
申请人: Stephen O'Connor , Gaetan Ladouceur , William Bullock , Ann-Marie Campbell , Miao Dai , Robert Dally , Jacques Dumas , Holia Hatoum-Mokdad , Uday Khire , Wendy Lee , Qingjie Liu , Derek Lowe , Steven Magnuson , Ning Qi , Tatiana Skelekhin , Quanrong Shen , Roger Smith , Ming Wang
发明人: Stephen O'Connor , Gaetan Ladouceur , William Bullock , Ann-Marie Campbell , Miao Dai , Robert Dally , Jacques Dumas , Holia Hatoum-Mokdad , Uday Khire , Wendy Lee , Qingjie Liu , Derek Lowe , Steven Magnuson , Ning Qi , Tatiana Skelekhin , Quanrong Shen , Roger Smith , Ming Wang
IPC分类号: A61K31/353 , A61K31/357 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61K31/506 , A61K31/69 , A61P1/04 , A61P3/04 , A61P3/06 , A61P3/10 , A61P5/48 , A61P9/10 , A61P13/12 , C07D311/58 , C07D405/12 , C07D405/14 , C07D407/04 , C07D407/12 , C07D407/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/14 , C07D45/02
CPC分类号: C07D405/12 , C07D311/58 , C07D405/14 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/14
摘要: This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.
摘要翻译: 本发明涉及可用于治疗β-3肾上腺素受体介导的病症的新的2,6-取代的苯并二氢吡喃衍生物。
-
9.1, 8-Naphthyridine derivatives and their use to treat diabetes and related disorders 审中-公开
标题翻译: 1,8-萘啶衍生物及其用于治疗糖尿病和相关疾病的用途公开(公告)号:US20060189609A1
公开(公告)日:2006-08-24
申请号:US11409536
申请日:2006-04-21
申请人: Yamin Wang , William Bullock , David Gunn , Qingjie Liu , Sidney Liang , Donglei Liu , Steven Magnuson , Tindy Li , Eric Mull , Jill Wood , Ning Qi
发明人: Yamin Wang , William Bullock , David Gunn , Qingjie Liu , Sidney Liang , Donglei Liu , Steven Magnuson , Tindy Li , Eric Mull , Jill Wood , Ning Qi
IPC分类号: A61K31/5377 , A61K31/496 , A61K31/4745 , C07D471/02
CPC分类号: A61K45/06 , A61K31/44 , A61K31/496 , A61K31/5377 , A61K31/541 , C07D471/04 , A61K2300/00
摘要: The invention relates generally to naphthyridine derivatives of the formula wherein one of U, X, Y and Z is nitrogen and the others are C—R, where R is hydrogen or a substituent. More specifically, the invention relates to 1,8-naphthyridine derivatives and pharmaceutical compositions containing such derivatives. Methods of the invention comprise administration of a naphthyridine derivative of the invention for the treatment of diabetes and related disorders.
摘要翻译: 本发明一般涉及下式的萘啶衍生物,其中U,X,Y和Z中的一个为氮,其余为C-R,其中R为氢或取代基。 更具体地,本发明涉及1,8-萘啶衍生物和含有这些衍生物的药物组合物。 本发明的方法包括施用本发明的萘啶衍生物用于治疗糖尿病和相关疾病。
-
10.2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists 失效
标题翻译: 用作β-3肾上腺素受体激动剂的2,6-取代的苯并二氢吡喃衍生物公开(公告)号:US06660752B2
公开(公告)日:2003-12-09
申请号:US10131448
申请日:2002-04-22
申请人: Stephen J. O'Connor , Gaetan H. Ladouceur , William H. Bullock , Ann-Marie Campbell , Miao Dai , Robert Dally , Jacques Dumas , Holia N. Hatoum-Mokdad , Uday Khire , Wendy Lee , Qingjie Liu , Derek B. Lowe , Steven R. Magnuson , Ning Qi , Tatiana E. Shelekhin , Quanrong Shen , Roger A. Smith , Ming Wang
发明人: Stephen J. O'Connor , Gaetan H. Ladouceur , William H. Bullock , Ann-Marie Campbell , Miao Dai , Robert Dally , Jacques Dumas , Holia N. Hatoum-Mokdad , Uday Khire , Wendy Lee , Qingjie Liu , Derek B. Lowe , Steven R. Magnuson , Ning Qi , Tatiana E. Shelekhin , Quanrong Shen , Roger A. Smith , Ming Wang
IPC分类号: A61K3144
CPC分类号: C07D405/12 , C07D311/58 , C07D405/14 , C07D407/12 , C07D409/12 , C07D413/12 , C07D417/14
摘要: This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.
摘要翻译: 本发明涉及可用于治疗β-3肾上腺素受体介导的病症的新的2,6-取代的苯并二氢吡喃衍生物。
-
-
-
-
-
-
-
-
-